Correction to: A new approach of nano-metformin as a protector against radiation-induced cardiac fibrosis and inflammation via CXCL1/TGF-&#914; pathway.

Karam, Heba M; Lotfy, Dina M; Ibrahim, Ayman A; Mosallam, Farag M; Abdelrahman, Sahar S; Abd-ElRaouf, Amira

Correction to: A new approach of nano-metformin as a protector against radiation-induced cardiac fibrosis and inflammation via CXCL1/TGF-Β pathway.

Karam, Heba M; Lotfy, Dina M; Ibrahim, Ayman A; Mosallam, Farag M; Abdelrahman, Sahar S; Abd-ElRaouf, Amira.

Afiliação

Karam HM; Drug Radiation Research Department, National Center for Radiation Research and Technology, Egyptian Atomic Energy Authority, Cairo, Egypt. heba.karam.mohmed@gmail.com.
Lotfy DM; Drug Radiation Research Department, National Center for Radiation Research and Technology, Egyptian Atomic Energy Authority, Cairo, Egypt.
Ibrahim AA; Drug Radiation Research Department, National Center for Radiation Research and Technology, Egyptian Atomic Energy Authority, Cairo, Egypt.
Mosallam FM; Department of Chemistry and Chemical Biology, McMaster University, 1280 Main Street West, Hamilton, ON, L8S4L8, Canada.
Abdelrahman SS; Drug Radiation Research Department, National Center for Radiation Research and Technology, Egyptian Atomic Energy Authority, Cairo, Egypt. farag.abomosalam@eaea.org.eg.
Abd-ElRaouf A; Anatomic Pathology Department, Faculty of Veterinary medicine, Cairo University, Cairo, Egypt.

Naunyn Schmiedebergs Arch Pharmacol ; 2024 Jun 01.

Article em En | MEDLINE | ID: mdl-38822869

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Naunyn Schmiedebergs Arch Pharmacol Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google